Understanding modern weight-loss medications.

GLP-1 medications — semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) — mimic a natural gut hormone that helps regulate appetite, blood sugar, and the rate at which the stomach empties.

Originally developed for type 2 diabetes, these injectables have become the most studied class of weight-management drugs in modern medicine. For many people, they quiet what users often call “food noise” — the constant background hum of thinking about food.

The first few weeks can feel strange. Hunger softens before the scale moves. Favorite foods sometimes lose their appeal. Energy can dip and then steady. Some people lose appetite almost completely.

Many users report changes that have nothing to do with weight — better sleep, calmer cravings, less reactive eating, a quieter relationship with food. The journey is rarely just about the scale.

Weight loss isn’t always linear. Plateaus are normal. Water shifts, hormonal cycles, sleep, and stress all move the number on the scale far more than fat loss does week to week.

Tracking protein, hydration, symptoms, sleep, and measurements creates a much more honest picture of what’s actually changing — and helps you and your prescriber make better decisions about dose, timing, and nutrition.